Loading...
Cochlear Limited
CHEOY•PNK
HealthcareMedical - Devices
$88.18
$0.17(0.19%)
Cochlear Limited (CHEOY) Stock Overview
Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
15.47%
↑ 15.47%
Profit Growth
$5.43
↑ 18.70%
EPS Growth
$5.43
↑ 19.04%
Operating Margin
21.70%
↑ 26.45%
ROE
19.70%
↑ 18.70%
Dividend Yield
0.00%
↑ 24.91%
Analyst Recommendations
Strong Buy
Buy
Hold
Sell
Strong Sell
Price Targets
Low$305.00
Average$318.50
High$332.00
Company Profile
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
CEO
Mr. Diggory William Howitt BE (Hons), MBA
Employees
4,996
Headquarters
1 University Avenue, Sydney, NSW
Founded
2010